Tag: FTC

The US Patent and Trademark Office (USPTO) recently proposed a rulemaking on terminal disclaimer practice, which received comments from various organizations before the deadline on July 9. One of the key commenters was the...

In a recent court ruling, the United States District Court for the District of New Jersey has determined that Teva's inhaler patents were incorrectly listed in the FDA's Orange Book. This decision supports Amneal's...